Vulvovaginal lichen planus treatment: a survey of current practices.
Cooper
Susan M
SM
Haefner
Hope K
HK
Abrahams-Gessel
Shafika
S
Margesson
Lynette J
LJ
D000284:Administration, Oral; D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007391:International Cooperation; D008010:Lichen Planus / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012720:Severity of Illness Index; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome; D014623:Vaginal Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014845:Vulvar Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D014848:Vulvovaginitis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D055815:Young Adult
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D016559:Tacrolimus